GO
Loading...

Health Care

More

  • I am a better person: Sam Waksal  Tuesday, 13 Jan 2015 | 8:36 AM ET

    Sam Waksal, former Imclone Systems CEO, reveals how the ImClone scandal has impacted his life.

  • J&J CEO: Too early to fully assess Obamacare  Monday, 12 Jan 2015 | 5:43 PM ET

    Alex Gorsky, Johnson & Johnson chairman and CEO, discusses how the ACA and the recovery in the economy is impacting business.

  • Shire CEO: $5.2 billion NPS deal will pay off  Monday, 12 Jan 2015 | 5:16 PM ET

    Flemming Ornskov, Shire CEO, tells CNBC's Meg TIrrell it is the right time for the proposed acquisition of NPS Pharmaceuticals.

  • Merck CEO: Deals create value  Monday, 12 Jan 2015 | 4:27 PM ET

    Merck CEO Ken Frazier plans to focus on its specialized area strategy in 2015, with CNCB's Meg Tirrell.

  • Biogen Idec beefs up pain pipeline  Monday, 12 Jan 2015 | 3:16 PM ET

    Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.

  • Targeting cancer's metabolism  Monday, 12 Jan 2015 | 2:46 PM ET

    Dr. David Schenkein, Agios CEO, explains a cancer's metabolism, and the company's priorities for 2015.

  • Bluebird's catalysts in 2015  Monday, 12 Jan 2015 | 1:44 PM ET

    Bluebird Bio CEO Nick Leschly, provides insight to how gene therapy can work to treat blood disorders, and sickle cell anemia.

  • Actavis CEO: Good can come from activists  Monday, 12 Jan 2015 | 12:38 PM ET

    Brent Saunders, Actavis CEO, discusses the deal environment, the process of acquiring Allergan and the good that comes from activist investors.

  • Celgene CEO: Creating a great future  Monday, 12 Jan 2015 | 11:45 AM ET

    CNBC's Meg Tirrell speaks to Robert Hugin, Celgene chairman & CEO, about the company's ambitious long-term guidance and broad-based drug pipeline.

  • Analyzing Eli Lilly's drug pipeline  Monday, 12 Jan 2015 | 10:15 AM ET

    CNBC's Meg Tirrell speaks to John Lechleiter, Eli Lilly CEO, about the strength and outlook for the health care sector, and what new drugs he's most excited about.

  • The great Obamacare-Medicaid bait 'n' switch Monday, 12 Jan 2015 | 2:21 PM ET

    More and more Americans are "covered," but fewer and fewer Americans will actually be able to get health care, says Jake Novak. Here's why.

  • Big deals, data kick off JPMorgan health conference Monday, 12 Jan 2015 | 1:04 AM ET

    The JPMorgan health care conference hadn't even officially begun when the first big piece of news of the week hit: Irish drugmaker Shire said Sunday morning it's purchasing orphan-drug company NPS Pharmaceuticals for $5.2 billion.

  • $1.8B drug deal to target cancer at genetic level Monday, 12 Jan 2015 | 8:05 AM ET

    Foundation Medicine CEO Michael Pellini tells CNBC, "It's an important day for patients battling cancer."

  • Goldman Sachs: Watch out for energy M&A in 2015 Monday, 12 Jan 2015 | 7:14 AM ET
    A derrick hand removes the the plastic caps off the threaded ends of pipe used in the drilling process in Knox County, Ohio.

    Healthcare M&A looks set to be strong again this year, following deals from Shire and Roche. But Goldman Sachs says energy's a sector to watch too.

  • Shire buys NPS Pharma in $5.2 billion deal Sunday, 11 Jan 2015 | 12:08 PM ET

    Shire said it will acquire NPS Pharmaceuticals in an all-stock transaction for about $5.2 billion, the companies said on Sunday.

  • Ten year flu shot near reality: Mount Sinai CEO Sunday, 11 Jan 2015 | 9:00 AM ET

    A flu shot that lasts 10 years could be a reality soon, a top hospital executive told CNBC, along with "real steps" toward a cancer vaccine.

  • 'Nastier' flu strain spreads, death toll rises Friday, 9 Jan 2015 | 1:21 PM ET
    A person getting a flu vaccination shot in Chicago last November.

    Twenty-six children have died from the flu this season, and the rate of hospitalization among the elderly is rising, the CDC says.

  • Gyms feel the burn of wearable tech, high rents Saturday, 10 Jan 2015 | 1:00 PM ET

    Fitness club operators shouldn't look at wearables as a threat, but an opportunity, said Equinox Fitness CEO Harvey Spevak.

  • Health care start-ups rake in record money in 2014 Friday, 9 Jan 2015 | 12:58 PM ET
    The Fitbit Flex

    Ask venture capitalists in Silicon Valley about which industry they're most excited to revolutionize, and odds are high that they'll say health care.

  • How to play the JPMorgan health conference Friday, 9 Jan 2015 | 11:57 AM ET
    Ariad Pharmaceuticals Medicinal Chemist Nick Bencivenga works in the company's lab.

    History says the best play is to buy biotech stocks the day before the JPMorgan meeting starts and hold until the end.

Contact Health Care

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More

 

  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.